This new color is part of a bigger push to phase out artificial dyes, which have raised concerns in recent years.

Nostrum Labs is recalling all lots within expiry of Sucralfate Tablets 1g as the Company has shut down operations at its US sites and is unable to assure the quality of the product.

Fifteen of 20 HLA-matched living donor recipients achieved the primary end point of being immunosuppression-free for more than 2 years.

Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.

HealthDay News — Approved label populations for new drugs are broader than trial populations overall, according to a study published online July 8 in the Annals of Internal Medicine.

No significantly increased risks observed for autoimmune disorder, atopic or allergic disorder, neurodevelopmental disorder.

The CUP-DIU study explored the relationship between IUD displacement and the use of a menstrual cup in 747 women who consulted for follow-up of their IUD at 2 primary care facilities in Paris.

Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD ...

OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.

The USPSTF meets several times a year to review the latest science and decide which screenings, medications and other preventive services should be fully covered by insurance.

Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes.